Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A known ✓ | P28223 | 3/20 | 0.50 |
| ▸ | HTR7 known ✓ | P34969 | 2/20 | 0.49 |
| ▸ | HTR2B known ✓ | P41595 | 2/20 | 0.49 |
| ▸ | HDAC3 known ✓ | O15379 | 1/20 | 0.38 |
| ▸ | HDAC4 known ✓ | P56524 | 1/20 | 0.38 |
| ▸ | HDAC7 known ✓ | Q8WUI4 | 1/20 | 0.38 |
| ▸ | HDAC8 known ✓ | Q9BY41 | 1/20 | 0.38 |
| ▸ | HDAC6 known ✓ | Q9UBN7 | 1/20 | 0.38 |
| ▸ | HDAC9 known ✓ | Q9UKV0 | 1/20 | 0.38 |
| ▸ | HDAC5 known ✓ | Q9UQL6 | 1/20 | 0.38 |
| ▸ | CA2 known ✓ | P00918 | 1/20 | 0.38 |
| ▸ | GPR3 | P46089 | 2/20 | 0.44 |
| ▸ | ANPEP | P15144 | 2/20 | 0.41 |
| ▸ | KDM1A | O60341 | 5/20 | 0.38 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29444048 | 0.97 | HTR2A (0.52) | HTR2AHTR7HTR2BGPR3ANPEP | |
| SCHEMBL353865 | 0.97 | HTR2A (0.52) | HTR2AHTR7HTR2BGPR3ANPEP | |
| SCHEMBL30410319 | 0.97 | HTR2A (0.52) | HTR2AHTR7HTR2BGPR3ANPEP | |
| SCHEMBL22270015 | 0.94 | HTR2A (0.50) | HTR2AHTR7HTR2BGPR3ANPEP | |
| Bromide SCHEMBL4922157 | 0.94 | HTR2A (0.50) | HTR2AHTR7HTR2BGPR3ANPEP | |
| Water SCHEMBL28455469 | 0.94 | HTR2A (0.50) | HTR2AHTR7HTR2BGPR3ANPEP | |
| Hydrochloric Acid SCHEMBL839294 | 0.92 | HTR2A (0.48) | HTR2AHTR7HTR2BGPR3ANPEP | |
| Dimethylamine SCHEMBL28473737 | 0.87 | HTR2A (0.44) | HTR2AHTR7HTR2BGPR3HDAC3 | |
| Biphenyl SCHEMBL21382703 | 0.87 | ALDH1A1 (0.45) | HTR2AHTR7HTR2BGPR3KDM1A | |
| Trimethylammonium SCHEMBL27603581 | 0.85 | GPR3 (0.54) | HTR2AHTR7HTR2BGPR3POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 270 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200131431-A1 | CHEMICAL ADDITIVES AND SURFACTANT COMBINATIONS FOR FAVORABLE WETTABILITY ALTERATION AND IMPROVED HYDROCARBON RECOVERY FACTORS | ALCHEMY SCIENCES INC (US) | 2020-04-30 | — | — | US | claimed |
| US-20170328837-A1 | SERS-BASED ANALYTE DETECTION | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2017-11-16 | — | — | US | claimed |
| US-9689801-B2 | SERS-based analyte detection | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2017-06-27 | — | — | US | claimed |
| EP-2516995-B1 | SERS-BASED ANALYTE DETECTION | AGENCY SCIENCE TECH & RES (SG) | 2016-10-26 | — | — | EP | claimed |
| CN-102812348-B | Analysis quality testing based on SERS is surveyed | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2016-02-03 | — | — | CN | claimed |
| US-20130023435-A1 | SERS-BASED ANALYTE DETECTION | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2013-01-24 | — | — | US | claimed |
| CN-102812348-A | SERS-based Analyte Detection | AGENCY SCIENCE TECH & RES | 2012-12-05 | — | — | CN | claimed |
| EP-2516995-A1 | SERS-BASED ANALYTE DETECTION | Agency For Science, Technology And Research (SG) | 2012-10-31 | — | — | EP | claimed |
| WO-2011078794-A1 | SERS-BASED ANALYTE DETECTION | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-06-30 | — | — | WO | claimed |
| CN-101880246-A | Substituted benzoyl urea compound and preparation method and application thereof | SHANGHAI INST MATERIA MEDICA | 2010-11-10 | — | — | CN | claimed |
| CN-1164534-C | Iron catalyst and its prepn and application | 中国科学院化学研究所 | 2004-09-01 | — | — | CN | claimed |
| CN-1398836-A | Iron catalyst and its prepn and application | CHINESE ACAD INST CHEMISTRY (CN) | 2003-02-26 | — | — | CN | claimed |
| US-20260139710-A1 | BEARING DEVICE, METHOD OF MANUFACTURING BEARING DEVICE, HARD DISK DRIVE DEVICE, AND MOTOR | MINEBEA MITSUMI INC (JP) | 2026-05-21 | — | — | US | disclosed |
| CN-122062050-A | Bearing device, method for manufacturing bearing device, hard disk drive device, and motor | 美蓓亚三美株式会社 | 2026-05-19 | — | — | CN | disclosed |
| US-12570673-B2 | c-Myc protein inhibitor, and preparation method therefor and use thereof | SUZHOU KINTOR PHARMACEUTICALS, INC. (CN) | 2026-03-10 | — | — | US | disclosed |
| EP-3712922-B1 | METHOD, DEVICE AND CARRIER MEDIUM FOR PREPARING MEASUREMENT SAMPLE FOR MALDI MASS SPECTROMETRY, MEASUREMENT SAMPLE FOR MALDI MASS SPECTROMETRY, AND MALDI MASS SPECTROMETRY METHOD | RICOH CO LTD (JP) | 2025-09-24 | — | — | EP | disclosed |
| US-4865994-A | REACTING 2-ANILINO-S-THIAZOLINONE MODIFIED AMINO ACID WITH AMINO COMPOUND LABELED WITH RADIOACTIVE ISOTOPE | SEIKO INSTRUMENTS & ELECTRONICS LTD. (JP) | 1989-09-12 | — | — | US | disclosed |
| US-4663313-A | N6 -tricyclic adenosines for treating hypertension | WARNER-LAMBERT COMPANY (US) | 1987-05-05 | — | — | US | disclosed |
| US-4593019-A | Therapy for psychosis | WARNER-LAMBERT COMPANY (US) | 1986-06-03 | — | — | US | disclosed |
| EP-0179630-A2 | N6-acenaphthyl adenosines and analogs thereof | WARNER-LAMBERT COMPANY (US) | 1986-04-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570673-B2 | c-Myc protein inhibitor, and preparation method therefor and use thereof | MYC, MYCBP, TP53 | HTR2A 4406/4885HTR7 4073/4885HTR2B 4303/4885 |
| US-20260139710-A1 | BEARING DEVICE, METHOD OF MANUFACTURING BEARING DEVICE, HARD DISK DRIVE DEVICE, AND MOTOR | ZW10, SOD1, EED | HTR2A 3641/4885HTR7 4721/4885HTR2B 4657/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.